Related Experiment Videos
Ritodrine and nifedipine as tocolytic agents: a preliminary comparison
K G van Dijk1, G A Dekker, H P van Geijn
1Department of Obstetrics and Gynecology, Free University Hospital, Amsterdam, The Netherlands.
Journal of Perinatal Medicine
|January 1, 1995
Summary
Nifedipine appears more effective than ritodrine for treating preterm labor, with fewer maternal side effects and better perinatal outcomes. Further research is recommended, but nifedipine is suggested for preterm labor management.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
Background:
- The efficacy of beta-mimetic drugs, like ritodrine, for preterm labor is debated due to side effects.
- Nifedipine, a calcium channel blocker, is a potential alternative tocolytic agent.
Purpose of the Study:
- To compare the efficacy and safety of nifedipine versus ritodrine in treating preterm labor.
- To assess the impact on delivery postponement, maternal side effects, and perinatal outcomes.
Main Methods:
- A retrospective study involving 32 patients treated with intravenous ritodrine and 29 patients treated with oral nifedipine.
- Evaluation of endpoints including delivery delay, maternal adverse events, and perinatal results.
Main Results:
- Nifedipine demonstrated greater success in postponing delivery compared to ritodrine.
- Ritodrine treatment was associated with more frequent and severe maternal side effects.
- Perinatal outcomes appeared more favorable in the nifedipine group.
Conclusions:
- Nifedipine shows promise as a more effective and safer tocolytic agent for preterm labor than ritodrine.
- The findings support further large-scale prospective studies to confirm nifedipine's role.
- Nifedipine is recommended for preterm labor, particularly in high-risk patients, to mitigate beta-mimetic side effects.